Annual Total Long Term Liabilities
$43.41 B
-$400.00 M-0.91%
31 December 2023
Summary:
Bristol-Myers Squibb annual total long term liabilities is currently $43.41 billion, with the most recent change of -$400.00 million (-0.91%) on 31 December 2023. During the last 3 years, it has fallen by -$18.11 billion (-29.43%). BMY annual total long term liabilities is now -29.43% below its all-time high of $61.52 billion, reached on 31 December 2020.BMY Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Liabilities
$53.83 B
-$480.00 M-0.88%
30 September 2024
Summary:
Bristol-Myers Squibb quarterly total long term liabilities is currently $53.83 billion, with the most recent change of -$480.00 million (-0.88%) on 30 September 2024. Over the past year, it has increased by +$15.09 billion (+38.96%). BMY quarterly long term liabilities is now -12.50% below its all-time high of $61.52 billion, reached on 31 December 2020.BMY Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BMY Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -0.9% | +39.0% |
| 3 y3 years | -29.4% | +3.2% |
| 5 y5 years | +325.4% | +84.4% |
BMY Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -29.4% | at low | -5.0% | +39.0% |
| 5 y | 5 years | -29.4% | +325.4% | -12.5% | +84.4% |
| alltime | all time | -29.4% | +6790.8% | -12.5% | +8444.8% |
Bristol-Myers Squibb Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $53.83 B(-0.9%) |
| June 2024 | - | $54.31 B(-4.1%) |
| Mar 2024 | - | $56.66 B(+30.5%) |
| Dec 2023 | $43.41 B(-0.9%) | $43.41 B(+12.1%) |
| Sept 2023 | - | $38.74 B(-6.2%) |
| June 2023 | - | $41.31 B(-4.6%) |
| Mar 2023 | - | $43.31 B(-1.1%) |
| Dec 2022 | $43.81 B(-14.8%) | $43.81 B(-5.8%) |
| Sept 2022 | - | $46.53 B(-0.5%) |
| June 2022 | - | $46.78 B(-3.7%) |
| Mar 2022 | - | $48.57 B(-5.6%) |
| Dec 2021 | $51.44 B(-16.4%) | $51.44 B(-1.4%) |
| Sept 2021 | - | $52.15 B(-5.1%) |
| June 2021 | - | $54.93 B(-4.4%) |
| Mar 2021 | - | $57.43 B(-6.6%) |
| Dec 2020 | $61.52 B(+2.6%) | $61.52 B(+12.2%) |
| Sept 2020 | - | $54.84 B(-1.2%) |
| June 2020 | - | $55.49 B(-7.6%) |
| Mar 2020 | - | $60.08 B(+0.2%) |
| Dec 2019 | $59.94 B(+487.4%) | $59.94 B(+105.4%) |
| Sept 2019 | - | $29.19 B(-0.4%) |
| June 2019 | - | $29.30 B(+174.5%) |
| Mar 2019 | - | $10.68 B(+4.6%) |
| Dec 2018 | $10.21 B(-15.9%) | $10.21 B(-0.8%) |
| Sept 2018 | - | $10.29 B(-0.5%) |
| June 2018 | - | $10.35 B(-2.0%) |
| Mar 2018 | - | $10.55 B(-13.1%) |
| Dec 2017 | $12.14 B(+42.5%) | $12.14 B(+26.1%) |
| Sept 2017 | - | $9.63 B(+0.6%) |
| June 2017 | - | $9.57 B(-3.4%) |
| Mar 2017 | - | $9.91 B(+16.3%) |
| Dec 2016 | $8.52 B(-8.5%) | $8.52 B(-4.8%) |
| Sept 2016 | - | $8.95 B(-9.3%) |
| June 2016 | - | $9.87 B(+1.3%) |
| Mar 2016 | - | $9.74 B(+4.7%) |
| Dec 2015 | $9.31 B(-9.7%) | $9.31 B(-0.4%) |
| Sept 2015 | - | $9.35 B(+1.3%) |
| June 2015 | - | $9.23 B(-9.5%) |
| Mar 2015 | - | $10.20 B(-1.0%) |
| Dec 2014 | $10.30 B(-5.6%) | $10.30 B(+1.6%) |
| Sept 2014 | - | $10.15 B(-1.7%) |
| June 2014 | - | $10.33 B(-0.4%) |
| Mar 2014 | - | $10.37 B(-5.0%) |
| Dec 2013 | $10.92 B(-21.9%) | $10.92 B(-21.0%) |
| Sept 2013 | - | $13.81 B(+2.1%) |
| June 2013 | - | $13.53 B(-2.3%) |
| Mar 2013 | - | $13.85 B(-1.0%) |
| Dec 2012 | $13.98 B(+50.0%) | $13.98 B(+0.2%) |
| Sept 2012 | - | $13.95 B(+57.4%) |
| June 2012 | - | $8.86 B(-1.0%) |
| Mar 2012 | - | $8.95 B(-4.0%) |
| Dec 2011 | $9.32 B(+7.2%) | $9.32 B(+12.8%) |
| Sept 2011 | - | $8.27 B(-0.2%) |
| June 2011 | - | $8.28 B(+1.0%) |
| Mar 2011 | - | $8.20 B(-5.8%) |
| Dec 2010 | $8.70 B(-12.2%) | $8.70 B(-9.1%) |
| June 2010 | - | $9.57 B(+0.7%) |
| Mar 2010 | - | $9.50 B(-4.1%) |
| Dec 2009 | $9.91 B(-6.2%) | $9.91 B(+7.9%) |
| Sept 2009 | - | $9.19 B(+0.6%) |
| June 2009 | - | $9.13 B(-8.1%) |
| Mar 2009 | - | $9.93 B(-6.0%) |
| Dec 2008 | $10.57 B(+51.7%) | $10.57 B(+23.1%) |
| Sept 2008 | - | $8.59 B(-0.7%) |
| June 2008 | - | $8.65 B(+18.1%) |
| Mar 2008 | - | $7.32 B(+5.1%) |
| Dec 2007 | $6.97 B(-23.3%) | $6.97 B(+1.0%) |
| Sept 2007 | - | $6.89 B(-29.1%) |
| June 2007 | - | $9.72 B(+2.1%) |
| Mar 2007 | - | $9.52 B(+4.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2006 | $9.09 B(-9.5%) | $9.09 B(-3.9%) |
| Sept 2006 | - | $9.46 B(-4.1%) |
| June 2006 | - | $9.86 B(-0.4%) |
| Mar 2006 | - | $9.90 B(-1.3%) |
| Dec 2005 | $10.04 B(-3.4%) | $10.04 B(+30.1%) |
| Sept 2005 | - | $7.72 B(-1.1%) |
| June 2005 | - | $7.80 B(-23.3%) |
| Mar 2005 | - | $10.18 B(-2.1%) |
| Dec 2004 | $10.39 B(+1.9%) | $10.39 B(-0.4%) |
| Sept 2004 | - | $10.43 B(+3.1%) |
| June 2004 | - | $10.11 B(-1.6%) |
| Mar 2004 | - | $10.28 B(+0.7%) |
| Dec 2003 | $10.20 B(+31.1%) | $10.20 B(+15.3%) |
| Sept 2003 | - | $8.85 B(+12.4%) |
| June 2003 | - | $7.87 B(+1.4%) |
| Mar 2003 | - | $7.76 B(-0.2%) |
| Dec 2002 | $7.78 B(+2.0%) | $7.78 B(+1.9%) |
| Sept 2002 | - | $7.63 B(+4.4%) |
| June 2002 | - | $7.31 B(-0.9%) |
| Mar 2002 | - | $7.38 B(-3.3%) |
| Dec 2001 | $7.63 B(+175.8%) | $7.63 B(-0.3%) |
| Sept 2001 | - | $7.65 B(+186.0%) |
| June 2001 | - | $2.68 B(-1.8%) |
| Mar 2001 | - | $2.72 B(-1.5%) |
| Dec 2000 | $2.77 B(-5.7%) | $2.77 B(+0.5%) |
| Sept 2000 | - | $2.75 B(-1.1%) |
| June 2000 | - | $2.78 B(-4.4%) |
| Mar 2000 | - | $2.91 B(-0.8%) |
| Dec 1999 | $2.93 B(+0.9%) | $2.93 B(+5.8%) |
| Sept 1999 | - | $2.77 B(-0.6%) |
| June 1999 | - | $2.79 B(-4.5%) |
| Mar 1999 | - | $2.92 B(+0.4%) |
| Dec 1998 | $2.90 B(+6.6%) | $2.90 B(+6.3%) |
| Sept 1998 | - | $2.73 B(-0.5%) |
| June 1998 | - | $2.75 B(-4.1%) |
| Mar 1998 | - | $2.87 B(+5.1%) |
| Dec 1997 | $2.73 B(-11.1%) | $2.73 B(-11.6%) |
| Sept 1997 | - | $3.08 B(+8.5%) |
| June 1997 | - | $2.84 B(-3.9%) |
| Mar 1997 | - | $2.96 B(-3.5%) |
| Dec 1996 | $3.06 B(-7.1%) | $3.06 B(+7.9%) |
| Sept 1996 | - | $2.84 B(-2.7%) |
| June 1996 | - | $2.92 B(-6.7%) |
| Mar 1996 | - | $3.13 B(-5.2%) |
| Dec 1995 | $3.30 B(+12.6%) | $3.30 B(+15.7%) |
| Sept 1995 | - | $2.85 B(-3.9%) |
| June 1995 | - | $2.97 B(+2.2%) |
| Mar 1995 | - | $2.91 B(-0.9%) |
| Dec 1994 | $2.93 B(-5.3%) | $2.93 B(-0.8%) |
| Sept 1994 | - | $2.96 B(-3.7%) |
| June 1994 | - | $3.07 B(-1.8%) |
| Mar 1994 | - | $3.13 B(+1.0%) |
| Dec 1993 | $3.10 B(+108.6%) | $3.10 B(+72.2%) |
| Sept 1993 | - | $1.80 B(-0.1%) |
| June 1993 | - | $1.80 B(+22.8%) |
| Mar 1993 | - | $1.47 B(-1.2%) |
| Dec 1992 | $1.48 B(+70.8%) | $1.48 B(+76.2%) |
| Sept 1992 | - | $842.00 M(+8.5%) |
| June 1992 | - | $776.00 M(-10.9%) |
| Mar 1992 | - | $871.00 M(+0.2%) |
| Dec 1991 | $869.00 M(-11.0%) | $869.00 M(-2.6%) |
| Sept 1991 | - | $892.00 M(+0.7%) |
| June 1991 | - | $886.00 M(-5.6%) |
| Mar 1991 | - | $939.00 M(-3.8%) |
| Dec 1990 | $976.00 M(+29.4%) | $976.00 M(-0.7%) |
| Sept 1990 | - | $983.00 M(+2.6%) |
| June 1990 | - | $958.00 M(+25.9%) |
| Mar 1990 | - | $761.00 M(+0.9%) |
| Dec 1989 | $754.00 M(+5.9%) | $754.00 M(+5.9%) |
| Dec 1988 | $712.00 M(+13.0%) | $712.00 M(+13.0%) |
| Dec 1987 | $630.00 M | $630.00 M |
FAQ
- What is Bristol-Myers Squibb annual total long term liabilities?
- What is the all time high annual total long term liabilities for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb annual total long term liabilities year-on-year change?
- What is Bristol-Myers Squibb quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Bristol-Myers Squibb?
- What is Bristol-Myers Squibb quarterly long term liabilities year-on-year change?
What is Bristol-Myers Squibb annual total long term liabilities?
The current annual total long term liabilities of BMY is $43.41 B
What is the all time high annual total long term liabilities for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high annual total long term liabilities is $61.52 B
What is Bristol-Myers Squibb annual total long term liabilities year-on-year change?
Over the past year, BMY annual total long term liabilities has changed by -$400.00 M (-0.91%)
What is Bristol-Myers Squibb quarterly total long term liabilities?
The current quarterly long term liabilities of BMY is $53.83 B
What is the all time high quarterly long term liabilities for Bristol-Myers Squibb?
Bristol-Myers Squibb all-time high quarterly total long term liabilities is $61.52 B
What is Bristol-Myers Squibb quarterly long term liabilities year-on-year change?
Over the past year, BMY quarterly total long term liabilities has changed by +$15.09 B (+38.96%)